Resmed to Report Third Quarter Fiscal 2025 Earnings on April 23, 2025
Resmed (NYSE: RMD, ASX: RMD) has announced it will release its third quarter fiscal 2025 financial and operational results on Wednesday, April 23, 2025, after the NYSE market close. The company will host a webcast to discuss the results at 1:30 p.m. PDT / 4:30 p.m. EDT on the same day.
The earnings webcast will be accessible through the investor relations section of Resmed's website. A replay will be available approximately two hours after the webcast, with a phone replay option available until May 7, 2025. Resmed, operating in 140 countries, specializes in AI-powered digital health solutions, cloud-connected devices, and intelligent software for home healthcare, focusing on sleep and breathing care.
Resmed (NYSE: RMD, ASX: RMD) ha annunciato che rilascerà i suoi risultati finanziari e operativi per il terzo trimestre dell'esercizio 2025 mercoledì 23 aprile 2025, dopo la chiusura del mercato NYSE. L'azienda ospiterà un webcast per discutere i risultati alle 13:30 PDT / 16:30 EDT dello stesso giorno.
Il webcast sugli utili sarà accessibile attraverso la sezione delle relazioni con gli investitori del sito web di Resmed. Una registrazione sarà disponibile circa due ore dopo il webcast, con un'opzione di registrazione telefonica disponibile fino al 7 maggio 2025. Resmed, operante in 140 paesi, si specializza in soluzioni di salute digitale basate sull'IA, dispositivi connessi al cloud e software intelligente per la cura domiciliare, con un focus sulla cura del sonno e della respirazione.
Resmed (NYSE: RMD, ASX: RMD) ha anunciado que publicará sus resultados financieros y operativos del tercer trimestre del ejercicio fiscal 2025 el miércoles 23 de abril de 2025, después del cierre del mercado NYSE. La empresa llevará a cabo un webcast para discutir los resultados a la 1:30 p.m. PDT / 4:30 p.m. EDT del mismo día.
El webcast de ganancias será accesible a través de la sección de relaciones con inversores del sitio web de Resmed. Una repetición estará disponible aproximadamente dos horas después del webcast, con una opción de repetición telefónica disponible hasta el 7 de mayo de 2025. Resmed, que opera en 140 países, se especializa en soluciones de salud digital impulsadas por IA, dispositivos conectados a la nube y software inteligente para el cuidado en el hogar, centrándose en el cuidado del sueño y la respiración.
Resmed (NYSE: RMD, ASX: RMD)는 2025 회계연도 3분기 재무 및 운영 결과를 2025년 4월 23일 수요일 NYSE 시장 마감 후 발표할 것이라고 발표했습니다. 회사는 같은 날 오후 1시 30분 PDT / 오후 4시 30분 EDT에 결과를 논의하기 위한 웹캐스트를 주최할 예정입니다.
수익 웹캐스트는 Resmed 웹사이트의 투자자 관계 섹션을 통해 접근할 수 있습니다. 웹캐스트 후 약 2시간 후에 재생이 가능하며, 전화 재생 옵션은 2025년 5월 7일까지 제공됩니다. 140개국에서 운영되는 Resmed는 AI 기반의 디지털 건강 솔루션, 클라우드 연결 장치 및 홈 헬스케어를 위한 지능형 소프트웨어에 전문화되어 있으며, 수면 및 호흡 관리에 중점을 두고 있습니다.
Resmed (NYSE: RMD, ASX: RMD) a annoncé qu'il publiera ses résultats financiers et opérationnels pour le troisième trimestre de l'exercice 2025 le mercredi 23 avril 2025, après la fermeture du marché NYSE. L'entreprise organisera un webcast pour discuter des résultats à 13h30 PDT / 16h30 EDT le même jour.
Le webcast sur les résultats sera accessible via la section des relations investisseurs du site Web de Resmed. Une rediffusion sera disponible environ deux heures après le webcast, avec une option de rediffusion par téléphone disponible jusqu'au 7 mai 2025. Resmed, qui opère dans 140 pays, se spécialise dans les solutions de santé numérique alimentées par l'IA, les dispositifs connectés au cloud et les logiciels intelligents pour les soins à domicile, en se concentrant sur les soins du sommeil et de la respiration.
Resmed (NYSE: RMD, ASX: RMD) hat bekannt gegeben, dass es seine finanziellen und operativen Ergebnisse für das dritte Quartal des Geschäftsjahres 2025 am Mittwoch, den 23. April 2025, nach Börsenschluss an der NYSE veröffentlichen wird. Das Unternehmen wird am selben Tag um 13:30 Uhr PDT / 16:30 Uhr EDT ein Webcast zur Diskussion der Ergebnisse veranstalten.
Der Webcast zu den Ergebnissen wird über den Bereich für Investorenbeziehungen auf der Website von Resmed zugänglich sein. Eine Wiederholung wird etwa zwei Stunden nach dem Webcast verfügbar sein, mit einer telefonischen Wiederholungsoption bis zum 7. Mai 2025. Resmed, das in 140 Ländern tätig ist, spezialisiert sich auf KI-gestützte digitale Gesundheitslösungen, cloudverbundene Geräte und intelligente Software für die häusliche Gesundheitsversorgung mit einem Fokus auf Schlaf- und Atempflege.
- None.
- None.
SAN DIEGO, April 02, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the third quarter of fiscal year 2025 on Wednesday, April 23, 2025, after the New York Stock Exchange closes. Following the release, Resmed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast.
Earnings webcast details:
| • | Location: | https://investor.resmed.com | |
| • | Date: | Wednesday, April 23, 2025 | |
| • | Time: | 1:30 p.m. PDT / 4:30 p.m. EDT | |
| • | International: | London, Wednesday, April 23, 2025, 9:30 p.m. BST | |
| Sydney, Thursday, April 24, 2025, 6:30 a.m. AEST |
Please note, Resmed does not use outside phone lines to access the earnings call, the call is accessible via the above webcast link only.
A replay of the earnings webcast will be accessible on Resmed’s website and available approximately two hours after the webcast. In addition, a phone replay will be available approximately three hours after the webcast and will be accessible from April 23, 2025, until May 7, 2025, at:
| • | U.S.: +1 877.660.6853 | |
| • | International: +1 201.612.7415 | |
| • | Conference ID: 13752711 |
About Resmed
Resmed (NYSE: RMD, ASX: RMD) creates life-changing health technologies that people love. We’re relentlessly committed to pioneering innovative technology to empower millions of people in 140 countries to live happier, healthier lives. Our AI-powered digital health solutions, cloud-connected devices and intelligent software make home healthcare more personalized, accessible and effective. Ultimately, Resmed envisions a world where every person can achieve their full potential through better sleep and breathing, with care delivered in their own home. Learn more about how we’re redefining sleep health at Resmed.com and follow @Resmed.
| For investors | For media |
| +1 858.836.5000 | +1 619.510.1281 |
| investorrelations@Resmed.com | news@Resmed.com |
FAQ
When will Resmed (RMD) release its Q3 2025 earnings report?
How can investors access Resmed's (RMD) Q3 2025 earnings call?
How long will Resmed's (RMD) Q3 2025 earnings call replay be available?
What is Resmed's (RMD) current international market presence?
